- Home
- ITRG vs BNTC Comparison
ITRG vs BNTC Comparison
Compare ITRG & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- BNTC
- Stock Information
- Founded
- ITRG 1997
- BNTC 1995
- Country
- ITRG Canada
- BNTC United States
- Employees
- ITRG N/A
- BNTC N/A
- Industry
- ITRG Precious Metals
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- ITRG Basic Materials
- BNTC Health Care
- Exchange
- ITRG Nasdaq
- BNTC Nasdaq
- Market Cap
- ITRG 277.2M
- BNTC 366.6M
- IPO Year
- ITRG N/A
- BNTC N/A
- Fundamental
- Price
- ITRG $1.48
- BNTC $12.89
- Analyst Decision
- ITRG Strong Buy
- BNTC Strong Buy
- Analyst Count
- ITRG 1
- BNTC 6
- Target Price
- ITRG $2.75
- BNTC $23.83
- AVG Volume (30 Days)
- ITRG 1.1M
- BNTC 234.8K
- Earning Date
- ITRG 08-13-2025
- BNTC 05-14-2025
- Dividend Yield
- ITRG N/A
- BNTC N/A
- EPS Growth
- ITRG N/A
- BNTC N/A
- EPS
- ITRG N/A
- BNTC N/A
- Revenue
- ITRG $87,375,000.00
- BNTC N/A
- Revenue This Year
- ITRG $746.16
- BNTC N/A
- Revenue Next Year
- ITRG N/A
- BNTC N/A
- P/E Ratio
- ITRG N/A
- BNTC N/A
- Revenue Growth
- ITRG N/A
- BNTC N/A
- 52 Week Low
- ITRG $0.79
- BNTC $7.05
- 52 Week High
- ITRG $1.95
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- ITRG 43.07
- BNTC 50.13
- Support Level
- ITRG $1.44
- BNTC $12.57
- Resistance Level
- ITRG $1.55
- BNTC $13.88
- Average True Range (ATR)
- ITRG 0.08
- BNTC 1.18
- MACD
- ITRG -0.01
- BNTC 0.02
- Stochastic Oscillator
- ITRG 19.70
- BNTC 62.63
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.